NDC 69238-1344-01 - Albuterol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-1344
- Requested NDC
- 69238-1344-01
- Package NDCs from labels
- 69238-1344-1, 69238-1344-5, 69238-1344-01
- Manufacturer
- Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited
- Effective date
- 2026-04-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Tablets, USP (2 mg and 4 mg) Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2026-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-1344-1 | Albuterol | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 69238-1344-5 | Albuterol | 500 in 1 BOTTLE | TABLET | 500 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-1344 | ALBUTEROL TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241220_230d66fc-f62c-42a6-adb3-0a0f879c8ad4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69238-1344-1 | EA - Each | 69238-1344 | 29bb6679-5fac-4f19-876b-f576ef9db7de | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | QUAGEN PHARMACEUTICALS LLC | 99a490cc-e41d-436b-9cf3-8facb7ac714f | 2025-07-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 99782bc8-56d9-41f8-935e-0d0de27f0c34 | 2025-05-19 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 1c72fd84-7dbc-45d0-ab88-fb4221ce369f | 2025-05-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 264e2145-c7d4-4f4f-aa5b-9fe48a7c5b47 | 2025-05-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Bryant Ranch Prepack | 601a18ed-d66e-498f-a804-f1a3330827d4 | 2025-04-21 | Warnings, Adverse reactions | 197318 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | ae35ec1f-526a-49bf-8262-c50e40190d1f | 2025-04-08 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | a6545fbe-b0a6-41ae-8bb6-91af38410f56 | 2025-04-01 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Chartwell RX, LLC | 560df50c-e2c4-459f-9d89-bf7e6588949e | 2025-03-28 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Nephron Pharmaceuticals Corporation | ecc00500-58b8-491f-80df-dc6c89a08cae | 2025-03-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Rising Pharma Holdings, Inc. | 40f3cdbc-c9ee-4a3c-8061-a44b9a1d035c | 2025-03-06 | Warnings, Adverse reactions | 197316 197318 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 813d49be-3651-6759-e053-2991aa0a6a9f | 2025-02-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Lupin Pharmaceuticals, Inc. | 973b8686-c6ce-4280-85c4-c1e7ceab3c09 | 2025-01-23 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 749992b4-69e0-0cc8-e053-2991aa0aeb25 | 2025-01-08 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 9d4ef83f-8ca0-811e-e053-2995a90a6d0d | 2025-01-08 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 4aafc2dd-744d-4726-828f-70355aee6f70 | 2025-01-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 53eecdef-a7ff-4ca3-a313-d4b9c29c898d | 2025-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Advanced Rx of Tennessee, LLC | 04c8a345-0a0d-5a01-e063-6294a90a40d2 | 2024-12-31 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Advanced Rx Pharmacy of Tennessee, LLC | f44b325d-0f74-552c-e053-2995a90ac1c9 | 2024-12-31 | Warnings, Adverse reactions | 021SEF3731 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Albuterol Sulfate Inhalation | ALBUTEROL SULFATE | Amneal Pharmaceuticals NY LLC | 2e449282-ee58-4e36-b983-85c4e6f0864d | 2024-12-20 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.